A Phase 2 Study of Docetaxel Plus Apalutamide in Castration-Resistant Prostate Cancer Patients Post Abiraterone Acetate
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Apalutamide (Primary) ; Docetaxel (Primary) ; Leuprorelin; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Aug 2017 Status changed from not yet recruiting to recruiting.
- 19 Jun 2017 Planned initiation date changed from 1 Apr 2017 to 30 Jun 2017.